Avatrombopag to Promote Platelet Engraftment After Allo-HSCT

Summary

The purpose of the study is to evaluate the efficacy and safety of avatrombopag for the promotion of platelet engraftment after Allo-HSCT.

Timeline

Start

2021-12-01

Primary completion

2022-12-31

Completion

2023-11-30

Publications

• Background Zhou M, Qi J, Gu C, Wang H, Zhang Z, Wu D, Han Y. Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation. Ther Adv Hematol. 2022 Sep 28;13:20406207221127532. doi: 10.1177/20406207221127532. eCollection 2022.

Drugs

Indications